TSX Delisting Review - Thallion Pharmaceuticals Inc. (Symbol: TLN)

TORONTO, Nov. 8, 2012 /CNW/ - DELISTING REVIEW  Thallion Pharmaceuticals Inc. (the "Company") - Further to TSX Bulletin 2012-0786 dated July 11, 2012, TSX has extended its review of the eligibility of the Common Shares (Symbol: TLN) of the Company for continued listing for a period of 30 days.

About TMX Group (TSX-X)

TMX Group's key subsidiaries operate cash and derivative markets for multiple asset classes including equities, fixed income and energy. Toronto Stock Exchange, TSX Venture Exchange, TMX Select, Alpha Group, The Canadian Depository for Securities, Montreal Exchange, Canadian Derivatives Clearing Corporation, Natural Gas Exchange, Boston Options Exchange, Shorcan, Shorcan Energy Brokers, Equicom and other TMX Group companies provide listing markets, trading markets, clearing facilities, data products and other services to the global financial community.  TMX Group is headquartered in Toronto and operates offices across Canada (Montreal, Calgary and Vancouver), in key U.S. markets (New York, Houston, Boston and Chicago) as well as in London, Beijing and Sydney.  For more information about TMX Group, visit our website at www.tmx.com.  Follow TMX Group on Twitter at http://twitter.com/tmxgroup.

SOURCE: TMX GROUP INC.